Recent results of hematopoietic stem cell transplantation for thalassemia with busulfan-based conditioning regimen in France: improved thalassemia free survival despite frequent mixed chimerism. A retrospective study from the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)
Résumé
[No abstract available]
Mots clés
Busulfan
Chimerism
France
Hematopoietic Stem Cell Transplantation
Humans
Retrospective Studies
Societies, Medical
Stem Cell Transplantation
Thalassemia
Transplantation Conditioning
busulfan
cyclophosphamide
cyclosporine
ferritin
fludarabine
methotrexate
mycophenolate mofetil
thymocyte antibody
chimera
cohort analysis
controlled study
disease free survival
DNA extraction
drug dose reduction
engraftment
female
follow up
graft rejection
graft versus host reaction
hematopoietic stem cell transplantation
hemoglobin blood level
human
human cell
identifiable information
informed consent
iron blood level
iron overload
Letter
liver level
major clinical study
male
matched related donor
matched sibling donor
matched unrelated donor
multivariate analysis
myeloablative conditioning
nuclear magnetic resonance
real time polymerase chain reaction
retrospective study
transfusion dependent thalassemia
treatment outcome
medical society
procedures
stem cell transplantation
thalassemia
transplantation conditioning